Substituted pyrazolo-pyridine amides and their use as GluN2B receptor modulators | Patent Number 11618750

US 11618750 B2
Application Number16899823
Publication NumberUS 20210017168 A1
Pendency2 years, 9 months, 26 days
Filled DateJun 12, 2020
Priority DateJun 14, 2019
Publication DateJan 21, 2021
Expiration DateJun 13, 2039
Inventor/ApplicantsMichael A. LETAVIC
Andrew Samant
Akinola SOYODE-JOHNSON
Christa Chrovian
Christine GELIN
Brice STENNE
Michael A. Letavic
Curt DVORAK
Christa CHROVIAN
Brice Stenne
Curt Dvorak
Afton Hiscox
Afton HISCOX
Andrew SAMANT
Akinola Soyode-Johnson
Christine Gelin
ExaminesRAHMANI, NILOOFAR
Art Unit1625
Technology Center1600
Assignments
Janssen Pharmaceuticals Johnson & Johnson
Current
Janssen Pharmaceuticals Johnson & JohnsonJohnson & Johnson
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.